Interactions between DRD2/ANKK1 TaqIA Polymorphism and Dietary Factors Influence Plasma Triglyceride Concentrations in Diabetic Patients from Western Mexico: A Cross-sectional Study.
Omar Ramos-LópezRoberto Mejia-GodoyKevin J Frías-DelgadilloRafael Torres-ValadezAurelio Flores-GarcíaSergio Sánchez-EnríquezPedro Aguiar-GarcíaMartínez-López ErikaEloy A Zepeda-CarrilloPublished in: Nutrients (2019)
This study aimed to screen relevant interactions between DRD2/ANKK1 TaqIA polymorphism and dietary intakes with reference to phenotypical features in patients with T2D from western Mexico. In this cross-sectional study, a total of 175 T2D patients were enrolled. Dietary intake was evaluated using 3-day food records and appropriate software. Glycemic and blood lipid profiles were measured by standardized methods. Genotyping of the DRD2/ANKK1 TaqIA polymorphism was performed by the RFLP method. Gene-diet interactions regarding anthropometric and metabolic phenotypes were screened by adjusted multiple linear regression analyses. Genotype frequencies of the DRD2/ANKK1 TaqIA polymorphism were A1A1 (16.0%), A1A2 (52.6%), and A2A2 (31.4%). Statistically significant interactions between the DRD2/ANKK1 TaqIA genotypes and dietary factors in relation to blood triglyceride (TG) levels were found. Carriers of the A1 allele (A1A1 homozygotes plus A1A2 heterozygotes) were protected from TG increases by maltose intake (P int. = 0.023). Instead, A2A2 homozygotes were susceptible to TG rises through consumptions of total fat (P int. = 0.041), monounsaturated fatty acids (P int. = 0.001), and dietary cholesterol (P int. = 0.019). This study suggests that the interactions between DRD2/ANKK1 TaqIA polymorphism and dietary factors (sugar and fats) influence TG levels in diabetic patients.
Keyphrases
- fatty acid
- end stage renal disease
- type diabetes
- adipose tissue
- south africa
- genome wide
- ejection fraction
- gene expression
- chronic kidney disease
- body composition
- prognostic factors
- peritoneal dialysis
- risk factors
- low density lipoprotein
- insulin resistance
- skeletal muscle
- copy number
- weight gain
- patient reported outcomes